The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Monisov F.M.

Russian Research Institute of Health;
Federal Research Center of Nutrition and Biotechnology

Rugol L.V.

Russian Research Institute of Health

Zaletova T.S.

Federal Research Center of Nutrition and Biotechnology

Problems and prospects of medical care for obese patients

Authors:

Monisov F.M., Rugol L.V., Zaletova T.S.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(11): 21‑26

Read: 1111 times


To cite this article:

Monisov FM, Rugol LV, Zaletova TS. Problems and prospects of medical care for obese patients. Russian Journal of Preventive Medicine. 2024;27(11):21‑26. (In Russ.)
https://doi.org/10.17116/profmed20242711121

Recommended articles:
Challenges, problems and approaches to healthcare digi­tal technologies enha­ncement. Russian Journal of Preventive Medi­cine. 2024;(12):31-36
Is arti­ficial inte­lligence nece­ssary for healthcare system?. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):40-48

References:

  1. World Health Organisation. Obesity and overweight — 2021. Accessed September 05, 2024. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  2. Issledovanie Rosstata «Racion pitaniya zhitelej strany`». 2018. Accessed September 05, 2024. (In Russ.). https://rosstat.gov.ru/folder/313/document/70761
  3. Jaacks LM, Vandevijvere S, Pan A, et al. The Obesity Transition: Stages of the Global Epidemic. The Lancet. Diabetes and Endocrinology. 2019; 7(3):231.  https://doi.org/10.1016/S2213-8587(19)30026-9
  4. Informacionny`j byulleten` VOZ. Ozhirenie i izby`tochny`j ves. 2021. Accessed September 05, 2024. (In Russ.). https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight
  5. Anisimova KA, Vasilevskiy DI, Balandov SG, et al. Morbid obesity in clinical practice: modern treatment concepts. Pediatr. 2020;11(6):63-69. (In Russ.). https://doi.org/10.17816/PED11663-69
  6. Klinicheskie rekomendacii. Ozhirenie. 2020. Accessed September 05, 2024. (In Russ.). https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight
  7. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990—2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9
  8. Alferova VI, Mustafina SV. Prevalence of obesity in the adult population of the Russian Federation (literature review). Ozhirenie i metabolizm. 2022; 19(1):96-105. (In Russ.). https://doi.org/10.14341/omet12809
  9. Okati-Aliabad H, Ansari-Moghaddam A, Kargar S, et al. Prevalence of obesity and overweight among adults in the Middle East countries from 2000 to 2020: A systematic review and meta-analysis. Journal of Obesity. 2022; 3:807483. https://doi.org/10.1155/2022/8074837
  10. Drapkina OM, Kim OT. Obesogens: How is obesity related to the environmental situation? Russian Journal of Preventive Medicine. 2021;24(2):82-88. (In Russ.). https://doi.org/10.17116/profmed20212402182
  11. Puzikova OZ, Popova VA, Kozhin AA, et al. Microelement imbalance in adolescents with obesity living in conditions of anthropogenic pollution of the environment. Sovremennye problem nauki i obrazovaniya. 2023;3:72. (In Russ.).
  12. Verbovoy AF, Sharonova LA. Obesity: epidemiological, social and economic aspects, prevention. Endokrinologiya: Novosti. Mneniya. Obuchenie. 2019; 8(3):87-97. (In Russ.).
  13. Finkelstein EA, DiBonaventura MD, Burgess SM, et al. The costs of obesity in the workplace. Journal of Occupational and Environmental Medicine. 2010;52(10):971-976.  https://doi.org/10.1097/JOM.0b013e3181f274d2
  14. Cawley J, Rizzo JA, Haas, K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. Journal of Occupational and Environmental Medicine. 2007;49(12):1317-1324. https://doi.org/10.1097/jom.0b013e31815b56a0
  15. Destri K, Alves J, Gregório MJ, et al. Obesity-attributable costs of absenteeism among working adults in Portugal. BMC Public Health. 2022;22:978.  https://doi.org/10.1186/s12889-022-13337-z
  16. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA. 2003;289:187-193.  https://doi.org/10.1001/jama.289.2.187
  17. Lang IA, Llewellyn DJ, Alexander K, et al. Obesity, Physical Function, and Mortality in Older Adults. Journal of the American Geriatrics Society. 2008; 56:1474-1478. https://doi.org/10.1111/j.1532-5415.2008.01813.x
  18. McTigue K, Larson JC, Valoski A, et al. Mortality and Cardiac and Vascular Outcomes in Extremely Obese Women. JAMA. 2006;296(1):79-86.  https://doi.org/10.1001/jama.296.1.79
  19. Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. International Journal of Obesity. 2013;37(6):889-891.  https://doi.org/10.1038/ijo.2012.159
  20. Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obesity Reviews. 2011; 12:50-61.  https://doi.org/10.1111/j.1467-789x.2009.00708.x
  21. Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. International Journal of Obesity. 2005;29: 334-339. 
  22. Lifshits GI, Kokh NV, Kireeva VV, et al. Some molecular genetic mechanisms of the obesity and metabolic syndrome. Farmakogenetika I farmakogenomika. 2017;1:5-9. (In Russ.).
  23. Pereverzev SV, Svarovskaya AV. The relationship between anthropometric indices and adverse outcomes in patients with ischemic heart disease and obesity. Ateroskleroz. 2021;17(3):66. (In Russ.). https://doi.org/10.52727/2078-256X-2021-17-3-66-66
  24. De Gomzalez AB, Hartge O, Cerhan JR, et al. Body mass index and mortality among 1.46 million white adults. The New England Journal of Medicine. 2010;363:2211-2219. https://doi.org/10.1056/NEJMoa1000367
  25. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: A case-control study. Lancet. 2005;366:1640-1649. https://doi.org/10.1016/s0140-6736(05)67663-5
  26. Lebedeva OD. The dynamics of body composition in non-pharmacological rehabilitation of patients with cardiovascular diseases and concomitant obesity. Problems of Balneology, Physiotherapy and Exercise Therapy. 2021;98(3-2):115-116. (In Russ.). https://doi.org/10.17116/kurort20231000323
  27. Losik DV, Nikitin NA, Minin SM, et al. The relationship between epicardial adipose tissue and the prognosis of cardiovascular events. Russian Journal of Cardiology and Cardiovascular Surgery. 2021;14(4):253-258. (In Russ.). https://doi.org/10.17116/kardio202114041253
  28. Oh TH, Byeon JS, Myung SJ, et al. Visceral obesity as a risk factor for colorectal neoplasm. Journal of Gastroenterology and Hepatology. 2008; 23(3):411-417.  https://doi.org/10.1111/j.1440-1746.2007.05125.x
  29. Spivak H, Hewitt MF, Onn A, et al. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. American Journal of Surgery. 2005;189:27-32.  https://doi.org/10.1016/j.amjsurg.2004.06.038
  30. Dedov II, Mel’nichenko GA, Shestakova MV, et al. National clinical guidelines for the treatment of morbid obesity in adults. 3rd revision (treatment of morbid obesity in adults). Ozhirenie I metabolizm. 2018;15(1):53-70. (In Russ.). https://doi.org/10.14341/omet2018153-70
  31. Postanovlenie Pravitel`stva Rossijskoj Federacii ot 28.11.2014 № 1273 «O Programme gosudarstvenny`x garantij besplatnogo okazaniya grazhdanam medicinskoj pomoshhi na 2015 god i na planovy`j period 2016 i 2017 godov». Accessed September 05, 2024. (In Russ.). https://www.ffoms.gov.ru/system-oms/about-fund/questions-oms/normative-dokuments
  32. Wen X, Zhang B, Wu B, et al. Signaling pathways in obesity: Mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy. 2022;7:298.  https://doi.org/10.1038/s41392-022-01149-x
  33. Troshina EA, Ershova EV. Farmakoterapiyaozhireniya: chtonovogo? Pharmacotherapy of obesity: what’s new? Problemy endokrinologii. 2018;64(4): 270-276. (In Russ.). https://doi.org/10.14341/probl9315
  34. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes – 5-Year outcomes. The New England Journal Of Medicine. 2017;376(7):641-651.  https://doi.org/10.1056/nejmoa1600869
  35. Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255-265.  https://doi.org/10.1001/jama.2017.20897
  36. Marks BL, Rippe JM. The importance of fat free mass maintenance in weight loss programmes. Sports Medicine (Auckland, N.Z.). 1996;22(5):273-278.  https://doi.org/10.2165/00007256-199622050-00001

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.